Marwa Abozed - Antibiotic - Best Researcher Award

Zagazig University Faculty of Human Medicine - Egypt

AUTHOR PROFILE

ORCID

🌟 INTRODUCTION TO ACADEMIC EXCELLENCE

Dr. Marwa Fady Mohamed Abd El Hamed stands as a dedicated scholar and innovator in the field of microbiology with an enduring focus on Antibiotic resistance and biofilm-related infections. Her academic journey, rooted in the Faculty of Pharmacy, Zagazig University, led to a PhD and a trajectory of significant contributions in teaching, research, and global academic collaboration. As an Assistant Professor at the Modern University for Technology and Information, Dr. Marwa merges education with frontline research, particularly on Antibiotic resistance, natural antibiofilm agents, and microbial pathogenesis. Her tenure across academic institutions in Egypt and Saudi Arabia—Delta University, Al-Ghad International Colleges, Buraidah Private Colleges—equipped her with a rich interdisciplinary teaching portfolio. She enhanced her global insight as a visiting scholar at the University of Dayton, Ohio, expanding her expertise in microbiological innovation. Throughout her research and teaching career, Dr. Marwa has consistently prioritized infection control and the evolving threat of Antibiotic resistance. Her involvement in international conferences and editorial boards further reflects her prominence in the scientific community. Grounded in a vision for integrative and sustainable microbiological solutions, she remains committed to shaping the future of Antibiotic research and education through rigorous scientific pursuit and impactful knowledge dissemination.

📘 EARLY ACADEMIC PURSUITS

Dr. Marwa’s academic roots were firmly planted at Zagazig University, where she obtained her Bachelor's, Master's, and Ph.D. degrees from the Faculty of Pharmacy, with all degrees centered on microbiology and its intersection with Antibiotic studies. Her early academic interests were already aligned with understanding microbial infections and the pharmacological interventions necessary to counteract them. During her graduate years, she explored the dynamics of Antibiotic resistance and bacterial biofilms—two of the most pressing challenges in medical microbiology. Her master’s thesis delved into microbial behavior under pharmacological stress, while her doctoral work addressed innovative strategies to detect and neutralize biofilm-associated pathogens. This formative academic period laid the foundation for her later focus on natural antibiofilm agents and their synergy with conventional Antibiotic treatments. Her training included intensive workshops in presentation skills, communication, and quality control—all contributing to her role as an educator and researcher. With early exposure to advanced clinical laboratory techniques and strategic thinking in drug design and microbial diagnostics, Dr. Marwa became exceptionally skilled in bridging theoretical science with practical Antibiotic applications. This early phase fostered a lifelong passion for tackling microbial resistance, promoting Antibiotic stewardship, and mentoring the next generation of microbiologists dedicated to combating superbugs and infection control.

🧪 PROFESSIONAL ENDEAVORS IN MICROBIOLOGY

Dr. Marwa Fady has pursued an impressive professional trajectory, dedicating her expertise to both academic and clinical institutions. Her work spans roles as a lecturer, microbiologist, and quality coordinator at prestigious institutions including Delta University, Al-Ghad International Colleges, and Buraidah Private Colleges in Saudi Arabia. Throughout these roles, she consistently infused her curriculum with cutting-edge knowledge on Antibiotic resistance mechanisms, biofilm formation, and infection control. As a team leader for self-study and quality assurance at Al-Ghad, she integrated Antibiotic stewardship modules into program evaluations. Additionally, her responsibility for graduation projects in clinical laboratories allowed her to mentor students on the development of innovative Antibiotic testing methods and natural antimicrobial compound screenings. At Zagazig University Hospital, she contributed to infection control programs and joined quality teams addressing Antibiotic medication management. Her multidisciplinary teaching spans General Microbiology, Immunology, Clinical Bacteriology, and Public Health, where the theme of Antibiotic relevance remains ever-present. Each position Dr. Marwa held amplified her influence over how Antibiotic resistance is studied, taught, and applied. Her passion for practical impact, paired with research leadership, continues to empower students and peers to adopt more sustainable and effective Antibiotic applications across pharmacy and health sciences education.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Marwa Fady’s research portfolio is deeply rooted in exploring novel solutions to Antibiotic resistance and biofilm-associated infections. Her publications span internationally reputed journals and address themes like antibiofilm strategies, synergistic effects of natural compounds with Antibiotic agents, and microbial behavior modulation. Her 2025 publication on chitosan-based microneedles for antifungal delivery exemplifies translational research where drug delivery innovation meets microbiological efficacy. Other landmark studies include the use of graphene oxide-cranberry hydrogels in antibiofilm wound healing and pH-sensitive nanocarriers for antimicrobial therapy. Her pioneering research bridges nanotechnology and Antibiotic pharmacology, offering advanced drug delivery systems that enhance Antibiotic performance and reduce toxicity. Additionally, her in vivo and in silico analyses of natural products like Rumex vesicarius highlight her dedication to identifying sustainable antimicrobial alternatives. Her earlier works addressed bacterial behavior in NICUs and biofilm response to common clinical nutrients and Antibiotic combinations. Dr. Marwa’s scientific curiosity and methodical rigor continue to shape her vision: tackling microbial resistance through interdisciplinary research, natural agent discovery, and personalized Antibiotic therapy. She believes the future of Antibiotic science lies in precision, sustainability, and biocompatibility—principles she champions across every experiment, conference paper, and student thesis she mentors.

🏅 ACCOLADES AND RECOGNITION

Dr. Marwa Fady’s commitment to advancing Antibiotic science and microbiological education has earned her numerous accolades and distinguished appointments. She serves as an Editorial Board Member for Frontiers in Environmental Microbiology and is a reviewer for high-impact journals like Bentham, reflecting her global credibility in Antibiotic and biofilm research. Her speaking engagements at international conferences, such as the 7th International Conference on Drug Discovery and Therapy in UAE, have positioned her as a respected thought leader in natural Antibiotic innovations. At the First Scientific Conference of Microbiology at Zagazig University and subsequent symposia, she was honored for her engaging presentations and novel insights into Antibiotic synergy with phytochemicals. Her projects have often received institutional commendation for addressing real-world infection control challenges and for promoting novel biofilm inhibition techniques. Dr. Marwa’s teaching excellence, underscored by her student feedback and curriculum innovations in Antibiotic topics, has also been repeatedly recognized. Her role in designing self-evaluation frameworks and quality assurance models in education further highlight her leadership and system-thinking abilities. Every honor she receives reinforces her lifelong mission: to evolve Antibiotic science through rigorous inquiry, collaborative learning, and cross-disciplinary solutions.

🌍 IMPACT AND INFLUENCE

Dr. Marwa Fady’s influence transcends academia, impacting public health, clinical education, and pharmaceutical research. Her persistent focus on Antibiotic efficacy, resistance mechanisms, and biofilm mitigation has made her a leading voice in global microbiology networks. Through her teaching, she has mentored hundreds of students who now contribute to Antibiotic stewardship programs and infectious disease prevention across diverse health systems. Her published research is not only cited in academic texts but also used in practical settings where Antibiotic choices affect patient outcomes. Her collaborations with international researchers on multi-component delivery systems for Antibiotic drugs extend her impact beyond Egypt and Saudi Arabia to broader global healthcare systems. As a quality assurance expert, her frameworks for institutional improvement have empowered universities to embed Antibiotic safety and usage training across curricula. Moreover, her public health initiatives—particularly her infection control work at Zagazig University Hospital—continue to serve as best-practice models. Whether in a classroom, hospital ward, or scientific symposium, Dr. Marwa’s influence remains firmly tied to her vision of advancing Antibiotic science as a societal cornerstone. Her efforts resonate in every hospital protocol, student dissertation, and policy guideline that prioritizes responsible and effective Antibiotic application.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Marwa Fady is poised to leave a lasting legacy as a pioneer in Antibiotic resistance research and translational microbiology. Her career trajectory continues to evolve with an eye toward novel technologies, such as CRISPR-based bacterial gene editing and smart biomaterials for controlled Antibiotic release. She is actively developing interdisciplinary partnerships that integrate nanomedicine, artificial intelligence, and molecular diagnostics to personalize Antibiotic treatments. Her upcoming research aims to explore underutilized botanicals as sources for next-generation Antibiotic agents, thereby reducing the burden of synthetic drug overuse. Dr. Marwa also intends to establish an Antibiotic Research Innovation Center, where students and experts will jointly tackle the rise of multidrug-resistant pathogens. Her pedagogical reforms are designed to instill early awareness of Antibiotic stewardship in future pharmacists and clinical scientists. Through publications, mentorship, and cross-border collaborations, she is crafting a resilient scientific ecosystem where Antibiotic innovation thrives sustainably. Her future is not merely in research papers but in the clinical tools, protocols, and policies influenced by her insights. Dr. Marwa Fady’s legacy will remain embedded in every initiative that values responsible Antibiotic use, patient safety, and the relentless pursuit of microbial understanding for public health betterment.

NOTABLE PUBLICATION

Title: Chitosan-Based Intelligent Microneedles for Delivery of Amphotericin B Loaded Oleosomes: Antifungal Ocular Patch Targeting for Effective Against Fungal Keratitis Using Rabbit Model via TLR4/NLRP3 Pathway
Author: Marwa Fady
Journal: International Journal of Nanomedicine
Publication Date: 2025-04-30

Title: Polylactic-Co-Glycolic Acid/Alginate/Neem Oil-Reduced Graphene Oxide as a pH-Sensitive Nanocarrier for Hesperidin Drug Delivery: Antimicrobial and Acute Otitis Media Assessments
Authors: Saeed Al Zuhairy, Sammar Fathy Elhabal, Mohamed Fathi Mohamed Elrefai, Sandra Hababeh, Jakline Nelson, Marwa Fady, Nahla A. Elzohairy, Tassneim M. Ewedah, Ibrahim S. Mousa, Ahmed M. Hamdan
Journal: Pharmaceuticals
Publication Date: 2025-03-07

Title: Effect of β-sitosterol on PEL and PSL of Pseudomonas aeruginosa
Authors: Marwa Fady, Y. Irie, R.M. Aljowaie, S. Musaed Almutairi
Journal: Journal of King Saud University - Science
Publication Year: 2024

Title: Enhancing Photothermal Therapy for Antibiofilm Wound Healing: Insights from Graphene Oxide-Cranberry Nanosheet Loaded Hydrogel in vitro, in silico, and in vivo Evaluation
Authors: Sammar Elhabal, Saeed Al Zuhairy, Mohamed El-Nabarawi, Mohamed Elrefai, Mai Shoela, Sandra Hababeh, Jakline Nelson, Mohamed Abdel Khalek, Marwa Fady, Nahla Elzohairy, et al.
Journal: International Journal of Nanomedicine
Publication Date: 2024-12

Title: Evaluation of antibiofilm and cytotoxicity effect of Rumex vesicarius methanol extract
Authors: Marwa Fady, H. Rizwana, K.M. Alarjani, M.A. Alghamdi, S.S. Ibrahim, J. Geyer, A. Abbas
Journal: Open Chemistry
Publication Year: 2023

Title: Efficacy of Ethanol Extract from Leaves Of Malva parviflora to Inhibit Bacterial Biofilm Formation
Authors: Marwa Abozed, Nadia Hashish, Magda Gazer
Journal: Journal of Molecular Biology Research
Publication Date: 2018-04-19

Introduction of Antimicrobial

Antimicrobials are substances or agents used to kill or inhibit the growth of microorganisms, which include bacteria, viruses, fungi, and parasites. They are essential in treating infections caused by these microbes, preventing their spread, and protecting health. Here’s a more detailed breakdown:

Types of Antimicrobials:

Antibiotics: Specifically target bacteria. Examples include penicillin, amoxicillin, and tetracycline. Antibiotics can kill bacteria or stop them from growing, making them crucial in treating bacterial infections like pneumonia, strep throat, and urinary tract infections.

Antivirals: These target viruses. Examples include acyclovir, which is used to treat herpes, and oseltamivir (Tamiflu), used to treat influenza. Antivirals work by interfering with the virus’s ability to replicate inside the host’s cells.

Antifungals: These are used to combat fungal infections. Examples include fluconazole, used to treat yeast infections, and terbinafine, used for athlete’s foot. Antifungals work by disrupting the cell walls of fungi or interfering with their metabolism.

Antiparasitics: These target parasites, which can cause diseases like malaria or intestinal worm infections. Examples include chloroquine for malaria and albendazole for worm infestations.

How Antimicrobials Work:

Cell Wall Disruption: Some antimicrobials weaken or destroy the microbe’s cell wall or membrane, leading to cell death. For example, penicillin disrupts the formation of bacterial cell walls.

Protein Synthesis Inhibition: Some antimicrobials interfere with the microbe’s ability to produce essential proteins, stopping their growth and reproduction. Tetracycline, for instance, inhibits protein synthesis in bacteria.

DNA Replication Interference: Some antimicrobials prevent microbes from replicating their DNA, which is necessary for their reproduction. Fluoroquinolones, for example, block bacterial DNA replication.

Metabolic Pathway Disruption: Some target specific biochemical pathways essential for the microbe’s survival. For instance, sulfonamides inhibit the synthesis of folic acid in bacteria, which is crucial for their growth.

Importance of Antimicrobials:

Medical Use: Antimicrobials are vital in treating infections, performing surgeries (by preventing infections), and managing chronic diseases that weaken the immune system, like cancer or HIV/AIDS.

Agricultural Use: They are also used in agriculture to prevent and treat infections in livestock, ensuring food safety and animal health.

Food Safety: Antimicrobials are used to prevent the contamination of food products by harmful microbes, extending shelf life and reducing the risk of foodborne illnesses.

Challenges:

Antimicrobial Resistance (AMR): The overuse and misuse of antimicrobials, such as not completing prescribed courses of antibiotics or using them for non-bacterial infections, have led to the development of resistant strains of microbes. These resistant strains can survive and thrive even in the presence of antimicrobials, making infections harder to treat and increasing the risk of disease spread, severe illness, and death.

Antimicrobials play a crucial role in modern medicine and public health, but their effectiveness is threatened by the growing problem of resistance, which requires careful management and stewardship.